Results 221 to 230 of about 290,153 (304)
Programmed cell death and risk of diabetic retinopathy: a Mendelian randomization study. [PDF]
Chen Y +6 more
europepmc +1 more source
Retinal Microvascular Signs And Cognitive Ability In Elderly People With Type 2 Diabetes [PDF]
Deary, Ian J. +7 more
core
Abstract Purpose To evaluate patient‐reported outcome measures (PROMs) and visual function across four groups of public cataract patients: emmetropia, mini‐monovision, monovision with partial‐range of field (RoF) narrow intraocular lenses (IOLs) and patients implanted with partial‐RoF extended IOLs.
Anne Guldhammer Skov +4 more
wiley +1 more source
Diabetic Corneal Neuropathy Precedes and Is Associated With Diabetic Retinopathy. [PDF]
Liu C +7 more
europepmc +1 more source
Abstract Purpose To test inter‐observer variation of plus disease diagnoses among Norwegian ophthalmologists and treatment centres. Methods All ophthalmologists in Norway who make individual retinopathy of prematurity (ROP) treatment decisions were invited to grade retinal images using a web‐based image grading platform.
Dordi Austeng +4 more
wiley +1 more source
Vogt-Koyanagi-Harada disease recurrence after laser treatment: A case report. [PDF]
Muto T +4 more
europepmc +1 more source
Abstract Purpose Diabetic retinopathy (DR) is a frequent long‐term complication of diabetes. While hemodynamic changes are known risk factors for DR, the effect of coronary artery bypass grafting (CABG) on the development of DR is poorly investigated.
Lukas Greve Maschoreck +16 more
wiley +1 more source
Acute Unilateral Vision Loss Following Recombinant Zoster (Shingrix) Vaccination: A Case of Presumptive Purtscher-Like Retinopathy. [PDF]
Anderson HE, Sood S, Golshani C.
europepmc +1 more source
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car +3 more
wiley +1 more source
Statement of Retraction: lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway. [PDF]
europepmc +1 more source

